Three-dimensional and four-dimensional flow assessment in congenital heart disease.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
03 2020
Historique:
received: 13 08 2019
revised: 08 11 2019
accepted: 20 11 2019
pubmed: 21 12 2019
medline: 23 10 2020
entrez: 21 12 2019
Statut: ppublish

Résumé

Congenital heart disease (CHD) is the most common form of congenital defects, with an incidence of 8 per 1000 births. Due to major advances in diagnostics, perioperative care and surgical techniques, the survival rate of patients with CHD has improved dramatically. Conversely, although 70%-95% of infants with CHD survive into adulthood, the rate of long-term morbidity, which often requires (repeat) intervention, has increased. Recently, the role of altered haemodynamics in cardiac development and CHD has become a subject of interest. Patients with CHD often have abnormal blood flow patterns, either due to the primary cardiac defect or as a consequence of the surgical intervention(s). Research suggests that these abnormal blood flow patterns may contribute to diminished cardiac and vascular function. Serial assessment of haemodynamic parameters in patients with CHD may allow for improved understanding of the often complex haemodynamics in these patients and thereby potentially guide the timing and nature of interventions with the aim of preventing progression of cardiovascular deterioration. In this article we will discuss two novel non-invasive four-dimensional (4D) techniques to evaluate cardiovascular haemodynamics: 4D-flow cardiac magnetic resonance and computational fluid dynamics. This review focuses on the additional value of these two modalities in the evaluation of patients with CHD with abnormal flow patterns, who could benefit from advanced haemodynamic evaluation: patients with coarctation of the aorta, bicuspid aortic valve, tetralogy of Fallot and patients after Fontan palliation.

Identifiants

pubmed: 31857355
pii: heartjnl-2019-315797
doi: 10.1136/heartjnl-2019-315797
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-426

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Evangeline Warmerdam (E)

Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Pediatric Cardiology, Wilhelmina Children's Hospital University Medical Center, Utrecht, The Netherlands.

Gregor J Krings (GJ)

Pediatric Cardiology, Wilhelmina Children's Hospital University Medical Center, Utrecht, The Netherlands.

Tim Leiner (T)

Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.

Heynric B Grotenhuis (HB)

Pediatric Cardiology, Wilhelmina Children's Hospital University Medical Center, Utrecht, The Netherlands H.B.Grotenhuis@umcutrecht.nl.
Pediatric Cardiology, Universitair Medisch Centrum Utrecht - Locatie Wilhelmina Kinderziekenhuis, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH